These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7667952)

  • 1. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
    Russel AJ
    Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
    [No Abstract]   [Full Text] [Related]  

  • 2. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 3. Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
    Horiot JC
    Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
    Hennes HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):628-31. PubMed ID: 9445562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Navoban--the new 5HT3-antagonist].
    Internist (Berl); 1994 May; 35(5 Suppl):1-8. PubMed ID: 9209536
    [No Abstract]   [Full Text] [Related]  

  • 6. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological review of tropisetron].
    Yokoyama T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):219-26. PubMed ID: 10584235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment patterns for radiation-induced nausea and vomiting.
    Kinay M
    Acta Oncol; 2004 Sep; 43 Suppl 15():9-12. PubMed ID: 15370624
    [No Abstract]   [Full Text] [Related]  

  • 9. Nausea and vomiting in advanced cancer.
    Ang SK; Shoemaker LK; Davis MP
    Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases].
    Buiuc AI; Găleşanu MR
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of Navoban for managing nausea and vomiting during the aggressive chemotherapy of malignant neoplasms].
    Seliuzhitskiĭ IV; Eliseev SN
    Voen Med Zh; 1993 Oct; (10):35-6. PubMed ID: 8303850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the clinical use of navoban].
    Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
    Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
    [No Abstract]   [Full Text] [Related]  

  • 13. Tropisetron (Navoban): just another "setron"?
    Aapro MS
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):1-2. PubMed ID: 9113118
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical selection of antiemetics.
    Flake ZA; Scalley RD; Bailey AG
    Am Fam Physician; 2004 Mar; 69(5):1169-74. PubMed ID: 15023018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
    de Wit R; Aapro M; Blower PR
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of the ideal antiemetic.
    Seegenschmiedt MH
    Acta Oncol; 2004 Sep; 43 Suppl 15():13-8. PubMed ID: 15370625
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.
    Priestman TJ
    Can J Oncol; 1996 Feb; 6 Suppl 1():17-22. PubMed ID: 8853534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.